This profile was last updated on .
Is this you? Claim your profile.
+ Get 10 Free Contacts a Month
Please agree to the terms and conditions
35 Wilbur Street
Lynbrook, New York 11563
BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date. Injectable collagenase is marketed as XIAFLEX in the U.S. for the treatment of Dupuytren's contracture and Pe ... more
Controller and Chief Financial Officer
Biospecifics Technologies Corp - Executive Compensation, 2007, CEO Salaries, Bonuses, Stock Options
0001311547 Dobroff Lawrence 15 SOUTHWICK COURT NORTH PLAINVIEW NY 11803 0 1 0 0 Chief Financial Officer
0001311547 Dobroff Lawrence 15 SOUTHWICK COURT NORTH PLAINVIEW NY 11803 0 1 0 0 Chief Financial Offiicer
0001311547 Dobroff Lawrence 15 SOUTHWICK COURT NORTH PLAINVIEW NY 11803 0 1 0 0 CHIEF FINANCIAL OFFICER
In addition to the executive officers ...
In addition to the executive officers named above, the Company employs Lawrence Dobroff as its Chief Financial Officer.